$JAGX 4 SEC Filings

Filed On	Filing
12 Mar 2026	Form 4: Micek John, Director Received 7,377 shares as a grant or award · Granted 7,377 Stock Option (right to buy)
21 Jan 2026	Form 4: King Steven R., See Remarks Received 11,740 shares as a grant or award · Granted 11,740 Stock Option (right to buy)
21 Jan 2026	Form 4: Wolin Jonathan S., See Remarks Received 11,740 shares as a grant or award · Granted 11,740 Stock Option (right to buy)
21 Jan 2026	Form 4: Conte Lisa A, Director Received 28,592 shares as a grant or award · Granted 28,592 Stock Option (right to buy)
15 Dec 2025	Form 4: Chaturvedi Pravin R, Chief Scientific Officer Received 11,740 shares as a grant or award · Granted 11,740 Stock Option (right to buy)
15 Dec 2025	Form 4: Bochnowski James J, Director Received 6,363 shares as a grant or award · Granted 6,363 Stock Option (right to buy)
15 Dec 2025	Form 4: Siegel Jonathan B., Director Received 7,377 shares as a grant or award · Granted 7,377 Stock Option (right to buy)
15 Dec 2025	Form 4: Jayasuriya Anula, Director Received 5,870 shares as a grant or award · Granted 5,870 Stock Option (right to buy)
15 Dec 2025	Form 4: Lizak Carol R., Chief Financial Officer Received 11,740 shares as a grant or award · Granted 11,740 Stock Option (right to buy)
26 Jun 2025	Form 4: Siegel Jonathan B., Director Disposed of 9,000 Convertible Promissory Note (Disposition to Issuer) ($450M) · Granted 9,462 Convertible Promissory Note ($473M) · Granted 18,262 Warrant to Purchase Common Stock
26 Jun 2025	Form 4: Micek John, Director Disposed of 9,000 Convertible Promissory Note (Disposition to Issuer) ($450M) · Granted 9,462 Convertible Promissory Note ($473M) · Granted 18,262 Warrant to Purchase Common Stock
26 Jun 2025	Form 4: Bochnowski James J, Director Disposed of 27,002 Convertible Promissory Note (Disposition to Issuer) ($4.05B) · Granted 28,388 Convertible Promissory Note ($4.26B) · Granted 54,786 Warrant to Purchase Common Stock
26 Jun 2025	Form 4: King Steven R., See Remarks Disposed of 3,600 Convertible Promissory Note (Disposition to Issuer) ($72M) · Granted 3,785 Convertible Promissory Note ($75.7K) · Granted 7,304 Warrant to Purchase Common Stock
26 Jun 2025	Form 4: Chaturvedi Pravin R, Chief Scientific Officer Disposed of 3,600 Convertible Promissory Note (Disposition to Issuer) ($72M) · Granted 3,785 Convertible Promissory Note ($75.7M) · Granted 7,304 Warrant to Purchase Common Stock
26 Jun 2025	Form 4: Wolin Jonathan S., See Remarks Disposed of 9,000 Convertible Promissory Note (Disposition to Issuer) ($450M) · Granted 9,462 Convertible Promissory Note ($473M) · Granted 18,262 Warrant to Purchase Common Stock
26 Jun 2025	Form 4: Conte Lisa A, Director Disposed of 9,000 Convertible Promissory Note (Disposition to Issuer) ($450M) · Granted 9,462 Convertible Promissory Note ($473M) · Granted 18,262 Warrant to Purchase Common Stock
20 May 2025	Form 4: King Steven R., See Remarks Received 1 shares by exercise or conversion
20 May 2025	Form 4: Conte Lisa A, Director Received 2 shares by exercise or conversion
02 Apr 2025	Form 4: Micek John, Director Acquired 9,000 Convertible Promissory Note (Open Market Purchase) ($450M) · Acquired 9,000 Warrant to Purchase Common Stock (Open Market Purchase)
02 Apr 2025	Form 4: King Steven R., See Remarks Acquired 3,600 Convertible Promissory Note (Open Market Purchase) ($72M) · Acquired 3,600 Warrant to Purchase Common Stock (Open Market Purchase)

Comments